Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01014897 · ClinicalTrials.gov registry record · Phase 1

Transcranial Direct Current Stimulation (tDCS) in Chronic Stroke Recovery

A Phase 1 study of Stroke, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target
1
Study location

NCT01014897 is a Phase 1 study of Stroke that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 14 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01014897, a Phase 1 study of Stroke, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The hypothesis of this study is that different subgroups of stroke will respond differently to direct current stimulation.

Conditions Studied

Stroke

Interventions

  • DEVICE tDCS

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2009-04
Est. Completion 2016-10
Phase Phase 1

Sponsor

University of Texas Southwestern Medical Center

837 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01014897

The ClinicalTrials.gov registry entry for NCT01014897 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which tDCS is the first listed.

NCT01014897 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01014897 about?

NCT01014897 is a clinical study titled "Transcranial Direct Current Stimulation (tDCS) in Chronic Stroke Recovery". The hypothesis of this study is that different subgroups of stroke will respond differently to direct current stimulation.

What is the current status of trial NCT01014897?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2009-04. Estimated completion is 2016-10.

What conditions does trial NCT01014897 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT01014897?

The interventions under investigation include: tDCS (DEVICE).

Who is sponsoring clinical trial NCT01014897?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01014897 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.